-
There has been enormous controversy regarding the benefit/safety relationship of the COX-2 inhibitors, which were initially introduced in 1999. Recent issues of the New England Journal of Medicine contain numerous articles (3 original reports, 2 editorials) that deal with this complex and unhappy story.
-
Quantitating mitral regurgitation by echocardiography predicts clinical outcomes and those with an EROA of at least 40 mm2 should be considered for surgery.
-
There is a 6% incidence of IMH among patients presenting as acute aortic syndromes and it is as lethal as AD, especially in the ascending aorta and, thus, surgery should be considered for patients with type A IMH.
-
The data provide a picture of the evolving status of catheter ablation of atrial fibrillation in the period of 1995 through 2002.
-
Routine daily transtelephonic ECG monitoring detects often asymptomatic arrhythmia episodes in a significant proportion of patients after radiofrequency ablation.
-
-
Small individuals and women are at risk for RPH and high femoral artery sticks are associated with this complication.
-
In a community-based HCM cohort, ventricular and supraventricular tachyarrhythmias on AECG were frequent, but sudden death was uncommon.
-
The FDA has asked Pfizer to withdraw valdecoxib (Bextra) from the market due to safety concerns.
-
Pulmonary vein stenosis is a significant complication of atrial fibrillation ablation procedures that can occur insidiously late after the ablation.
